ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Mar 31, 2017
Sanofi: The First Victim in the Great Insulin Price War
The steady growth expected from Diabetes products has come to an abrupt halt. Is Sanofi adequately prepared to replace the revenue loss of its top-selling product?
Mar 30, 2017
Who’s Driving Who: The Future of the Automakers
Image Source: HimmelrichPR. Let’s dig into some recent developments surrounding the auto market, and how technological and strategic innovation could reshape the future of the space.
Mar 30, 2017
Analyzing Amgen's Sudden Fall
Amgen’s share price has run up in anticipation of positive results from its key pipeline product Repatha. Now that the results are out, doubt has crept in concerning the overall viability of the product. Let’s examine.
Mar 30, 2017
Is There Value in DaVita?
Image Source: US Census Bureau. With healthcare the primary focus in Washington, let’s evaluate the investment case for DaVita. We discuss how potential changes can impact the economics of the dialysis market.
Mar 27, 2017
Mednax: A Consolidator in the Healthcare Field
Image Source: Mednax. Neonatology and anesthesiology remain key revenue contributors for Mednax, but its teleradiology opportunity may propel its future growth prospects.
Mar 20, 2017
Dividend Increases/Decreases for the Week Ending March 17
Let's take a look at companies raising/lowering their dividends this week.
Mar 16, 2017
The “Year of Evangeline Adams” Continues
"...the S&P 500 has advanced more than 250% since the March 2009 panic bottom when it closed at 676.53 on the 9th of the month. Today, March 15, 2017, it closed at 2,385.26. The performance represents “a triple and then some” in the 8 years of this aging bull market. This is not performance on speculative small caps or risky biotechs, but on the largest companies in America. Please exercise prudence and care in all that you do." -- Brian Nelson, CFA
Mar 16, 2017
Buffalo Wild Wings: It’s Time to Start Delivering?
Best Ideas Newsletter portfolio holding Buffalo Wild Wings is battling a challenging operating environment. Management is searching for ways to shore up performance, but some shareholders are getting antsy. Is a BWLD-WING deal in the cards?
Mar 14, 2017
Intel Makes Strong Move into Autonomous Driving
Image Source: Intel. Newsletter portfolio holding Intel has agreed to acquire Mobileye, a leading provider for computer vision for Advanced Driver Assistance Systems (ADAS), for $15.3 billion in cash.
Mar 13, 2017
Dividend Increases/Decreases for the Week Ending March 10
Let's take a look at companies raising/lowering their dividends this week.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.